Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
The MELAS syndrome. Review of the literature: the role of the otologist..
Clin Otolaryngol Allied Sci. 29(1), 1-4.
(2004). Melatonin secretion is impaired in women with preeclampsia and an abnormal circadian blood pressure rhythm..
Ren Fail. 36(7), 1001-7.
(2014). MELTUMP: how to manage these lesions in the clinical routine..
G Ital Dermatol Venereol. 152(3), 266-269.
(2017). Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial..
Lancet Neurol. 9(10), 969-77.
(2010). Memantine's action against aminoglycoside-induced ototoxicity..
Eur Arch Otorhinolaryngol. 271(6), 1491-6.
(2014). Membrane proteome analysis of the green-sulfur bacteriumChlorobium tepidum.
ELECTROPHORESIS. 25(20), 3468 - 3474.
(2004). Membrane proteome of the green sulfur bacterium Chlorobium tepidum (syn. Chlorobaculum tepidum) analyzed by gel-based and gel-free methods.
Photosynthesis Research. 104(2-3), 153 - 162.
(2010). Memory B Cell Divergences upon Immunization Against Streptococcus pneumoniae in HIV-1-Infected Adults..
AIDS Res Hum Retroviruses. 31(11), 1053-4.
(2015). Memory Correlates of Alzheimer's Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study..
J Alzheimers Dis. 60(3), 1119-1128.
(2017). MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations..
Best Pract Res Clin Endocrinol Metab. 24(3), 425-37.
(2010). Meningioma of the conus medullaris mimicking neurofibroma--possibly radiation induced..
Spine J. 11(2), e11-5.
(2011). Meniscofibular ligament: how much do we know about this structure of the posterolateral corner of the knee: anatomical study and review of literature..
Surg Radiol Anat. 42(10), 1203-1208.
(2020). Meniscofibular ligament: morphology and functional significance of a relatively unknown anatomical structure..
Anat Res Int. 2012, 214784.
(2012). Menopausal Hormone Therapy and Cardiovascular Risk: Where are we Now?.
Curr Vasc Pharmacol. 17(6), 564-572.
(2019). Menopausal hormone therapy for the prevention of cardiovascular disease: Evidence-based customization..
Maturitas. 81(4), 421-2.
(2015). Menopausal hormone therapy for women with obesity in the era of COVID-19..
Case Rep Womens Health. 27, e00233.
(2020). Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver disease..
Hormones (Athens).
(2022). Menopause and its Cardiometabolic Consequences: Current Perspectives..
Curr Vasc Pharmacol. 17(6), 543-545.
(2019). Menopause and metabolic dysfunction-associated steatotic liver disease..
Maturitas. 108024.
(2024). Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic Perspectives..
Curr Vasc Pharmacol. 17(6), 546-555.
(2019). Menopause in women with multiple sclerosis: A systematic review..
Maturitas. 135, 68-73.
(2020). Menopause symptom management in women with dyslipidemias: An EMAS clinical guide..
Maturitas. 135, 82-88.
(2020). Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society..
Maturitas. 163, 1-14.
(2022). Menopause-associated risk of cardiovascular disease..
Endocr Connect. 11(4),
(2022).
(2020).